Table 7.
Baseline to 3-month changes in clinical and psychosocial outcomes (n=20)
| Outcome | Mean (SD) | Percent change | Effect size | |
|---|---|---|---|---|
| Pre | Post | |||
| Primary outcomes | ||||
| Hemoglobin A1ca | 8.0 (2.4) | 7.8 (2.1) | −3% | 0.14 |
| Medication nonadherence | 16.1 (4.0) | 14.7 (3.9) | −9% | 0.35 |
| Secondary outcomes | ||||
| Blood pressure, systolica | 127.6 (19.9) | 129.9 (20.0) | +2% | 0.20 |
| Blood pressure, diastolica | 80.9 (13.7) | 81.9 (10.2) | +1% | 0.13 |
| Necessity of taking medicines | 19.1 (5.7) | 20.3 (5.0) | +7% | 0.30 |
| Concerns about taking medicines | 16.6 (5.6) | 15.9 (5.2) | −4% | 0.20 |
| Negative beliefs about diabetes | 40.3 (11.6) | 36.7 (10.6) | −9% | 0.38 |
| Self-efficacy | 31.9 (5.0) | 33.0 (5.2) | +4% | 0.20 |
| Patient provider communication | 15.6 (2.0) | 15.9 (2.2) | +2% | 0.11 |
| Social support | 59.2 (22.6) | 60.1 (17.2) | +2% | 0.16 |
| Diabetes empowerment | 30.9 (10.3) | 31.3 (7.6) | +1% | 0.07 |
| Health literacy | 3.1 (1.9) | 2.9 (2.1) | −3% | 0.08 |
aBaseline data for clinical outcomes was collected for a buddy who did not complete the psychosocial measures, so n=21 for these outcomes